The Tokyo declaration.
Explore the source record for details and available documents.
Consumer Advocacy↗
Biomedical subjects
Kanji Shichikawa
Publications and source records attributed to Kanji Shichikawa.
Establishment of the International Assessment Committee of Bone and Joint Diseases.
During the International Conference of the Bone and Joint Decade, held in Tokyo in April 2002, the International Assessment Committee of Bone and Joint Diseases was established. This committee is responsible for data collection, effective prevention and treatment, supply of care provisions, costs and priorities, and measurement to determine the outcome of patients with bone and joint diseases. Study planning was initiated by the Japanese Committee of Assessment, in cooperation with the Bone and Joint Monitor Project conducted by Prof. Anthony Woolf. As a result of our studies, we expect to obtain data concerning international comparisons of incidence, prevalence, and impact, as well as secular trends regarding the burden of musculoskeletal conditions, risk factors, and outcomes of each condition. Described here are results of population-based studies regarding the prevalence of rheumatoid arthritis (RA), osteoarthritis, osteoporosis, and limb fractures in Japan compared with those in Western countries, as well as a comparison of secular trends of RA incidence between Japanese and European subjects.
Advisory Committees↗
[Depressive tendency in patients with RA].
OBJECTIVES: To determine if depression scores are higher in patients with RA and to identify risk factors for depression. METHOD: The subjects were 287 RA in-patients and outpatients. We investigated the tendency of depression by SDS of Zung and whether SDS is correlated with age, face scale, VAS (visual analog scale), MHAQ, class, BSG and CRP. We compared the frequency of depression tendency between those who took steroid and those who did not. Among 238 cases that we studied, 131 patients took steroid hormone and the rest did not. RESULTS: It was found that 113 out of 287 patients (about 39%) showed depression tendency. SDS was correlated with face scale (r = 0.55198 P = 0.0001) followed by VAS (r = 0.40772 P = 0.0001). However, SDS was not correlated with BSG, CRP, age and duration range. For the group who took steroid hormone, the average score of SDS was 38.63 (+/- 8.37). The average score for the other group who did not take steroid was 35.98 (+/- 7.97). As a result, it was measured by T-value that the group who took steroid hormone had higher SDS than the other group who did not take steroid.
Adult↗